Sinopharm | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
September 20, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, SEPTEMBER 20, 2025

Sinopharm

Sinopharm

FILE PHOTO: A vial labelled "Sinopharm COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration

Some Omicron sub-variants escaping antibodies from Sinopharm shot

Sinopharm protein-based booster stronger against Omicron than earlier shot -study

Sinopharm protein-based booster stronger against Omicron than earlier shot -study

Test tubes are seen in front of a displayed Sinopharm logo in this illustration taken, May 21, 2021. Photo: Reuters

UAE approves Sinopharm's protein-based vaccine

A nurse holds a vial of China's Sinopharm coronavirus disease (COVID-19) vaccine at a health center in Caracas, Venezuela March 7, 2021. REUTERS/Leonardo Fernandez Viloria

Local production of Sinopharm vaccine uncertain

Photo: Reuters

Sinopharm Covid-19 booster weaker against Omicron - study

A nurse holds a vial of China's Sinopharm coronavirus disease (COVID-19) vaccine at a health center in Caracas, Venezuela March 7, 2021. REUTERS/Leonardo Fernandez Viloria

Canada to allow entry of travelers fully vaccinated with Sinopharm

Photo: Courtesy

Special vaccination campaign at community clinics from Saturday

Photo: Reuters

50 lakh more doses of Sinopharm vaccine reach Dhaka

Over 54 lakh doses of Sinopharm vaccine reach Dhaka

Over 54 lakh doses of Sinopharm vaccine reach Dhaka

File photo

20 lakh Sinopharm jabs arrived from China

Pfizer-BioNTech mRNA vaccineVincent Kraut/ Photonews via Getty Images

10 lakh Pfizer doses to arrive Wednesday

A sign of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang

Peru study finds Sinopharm Covid vaccine 50.4% effective against infections

File photo

10 lakh Sinopharm doses arrive from China

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net